CAVANNA, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 346
EU - Europa 245
AS - Asia 125
AF - Africa 2
SA - Sud America 2
Totale 720
Nazione #
US - Stati Uniti d'America 344
CN - Cina 95
IE - Irlanda 89
SE - Svezia 75
IT - Italia 36
DE - Germania 23
SG - Singapore 13
IN - India 9
TR - Turchia 7
FI - Finlandia 6
CZ - Repubblica Ceca 4
BE - Belgio 3
GB - Regno Unito 3
CA - Canada 2
ES - Italia 2
NL - Olanda 2
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
FR - Francia 1
KR - Corea 1
Totale 720
Città #
Chandler 127
Dublin 89
Ashburn 33
Beijing 30
Shanghai 29
Princeton 14
Ann Arbor 12
Bremen 11
Parma 11
Falls Church 7
Wilmington 7
Helsinki 6
New York 6
Kocaeli 5
Rome 5
Brno 4
Dearborn 4
Des Moines 4
Grafing 4
Mumbai 4
Pune 4
Bologna 3
Brussels 3
Hebei 3
Jinan 3
Los Angeles 3
Munich 3
Norwalk 3
San Mateo 3
Seattle 3
Boardman 2
Edinburgh 2
Fairfield 2
Guangzhou 2
Hefei 2
Izmir 2
Jiaxing 2
Milan 2
Nanjing 2
Pavia 2
Taizhou 2
Tianjin 2
Trumbull 2
Valencia 2
Washington 2
Woodbridge 2
Abidjan 1
Buenos Aires 1
Cairo 1
Caserta 1
Changsha 1
Cormeilles-en-Parisis 1
Esslingen am Neckar 1
Ewijk 1
Frankfurt am Main 1
Fuzhou 1
Geislingen an der Steige 1
Haikou 1
Jacksonville 1
Lanzhou 1
Montreal 1
Nagold 1
Nanchang 1
Old Bridge 1
Padova 1
Phoenix 1
Redwood City 1
Rockville 1
Santa Clara 1
Shenyang 1
São Paulo 1
Toronto 1
Tulsa 1
Vienna 1
Totale 503
Nome #
Identification of acetylated derivatives of zearalenone as novel plant metabolites by high-resolution mass spectrometry 80
Egg product freshness evaluation: A metabolomic approach 79
Investigating the in vitro catabolic fate of Enniatin B in a human gastrointestinal and colonic model 78
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer 53
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 52
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 52
A non-targeted high-resolution mass spectrometry approach for the assessment of the geographical origin of durum wheat 52
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 50
GC-IMS and FGC-Enose fingerprint as screening tools for revealing extra virgin olive oil blending with soft-refined olive oils: A feasibility study 49
The scientific challenges in moving from targeted to non-targeted mass spectrometric methods for food fraud analysis: A proposed validation workflow to bring about a harmonized approach 44
A Non-Targeted High-Resolution Mass Spectrometry Study for Extra Virgin Olive Oil Adulteration with Soft Refined Oils: Preliminary Findings from Two Different Laboratories 43
Ion mobility spectrometry coupled to gas chromatography: A rapid tool to assess eggs freshness 38
Non-targeted high-resolution mass spectrometry study for evaluation of milk freshness 36
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 32
Totale 738
Categoria #
all - tutte 2.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 12 20 2 0 2 5 3 0 13 47 4 1
2020/202141 1 0 3 0 5 4 5 7 5 9 2 0
2021/202258 1 0 0 2 4 6 2 3 4 9 3 24
2022/2023365 28 45 22 37 32 42 2 35 106 0 11 5
2023/2024142 4 10 2 6 6 30 18 23 4 9 5 25
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 738